“Anybody in the production and processing of semen can use it, and it does not require any maintenance, calibration or cleaning after use”
ChemoMetec announces the market introduction of the NucleoCounter SP-100.
“This revolutionary new technology, will due to its cost efficiency, high accuracy and precision make manual cell and indirect methods obsolete.
“The NucleoCounter has made it possible for semen collection centres and semen processing facilities to perform a fast, objective and reliable cell count,” explains Rolf Singer, CEO and president of ChemoMetec.
“Anybody in the production and processing of semen can use it, and it does not require any maintenance, calibration or cleaning after use.
“It is truly a plug-and-play system with a disposable sample device”.
The NucleoCounter SP-100 is suitable for performing total cell count with a CV below 5%.
The instrument can be connected to a PC for documentation, data storage and image collection.
The patent-pending innovation is a combination of proven technologies such as fluorescence microscopy image processing and cell biology and is currently available in other versions within cell counts of, eg, mammalian cells and somatic cells.
